Danaparoid and blood lactate dehydrogenase increased Patient Reports February 13, 2012

Danaparoid Side Effects Report #5077936-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 02, 2006. Male patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, condition aggravated, haemoglobin decreased, platelet count increased, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with MICAFUNGIN, METHYLPREDNISOLONE SUCCINATE, PLATELETS, PLASMA PROTEIN FRACTION, CARBENIN. Patient died.

Danaparoid Side Effects Report #5118898-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, condition aggravated, haemoglobin decreased, pneumonia , upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5046810-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 23, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, haemoglobin decreased, hepatic function abnormal, pneumonia , renal impairment, upper gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with DORIPENEM HYDRATE, ROXATIDINE ACETATE. Patient died.

Danaparoid Side Effects Report #5083999-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.


Danaparoid Side Effects Report #5029101-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, platelet count decreased, prothrombin time prolonged, subdural haematoma. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.

Danaparoid Side Effects Report #5113496-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hepatic function abnormal, shock haemorrhagic, wound infection. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, CEFAZOLIN, AMIKACIN SULPHATE, SACCHARATED IRON OXIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5113491-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia postoperative, blood lactate dehydrogenase increased, condition aggravated, hepatic function abnormal, malnutrition, platelet count decreased, postoperative infection, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with IMIPENEM, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, MENATETRENONE, HYDROCORTISONE PHOSPHATE, GABEXATE MESILATE, CLINDAMYCIN, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #4568431-7
Danaparoid side effect was reported by a Consumer or non-health professional from on Jan 25, 2005. Female patient, 74 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, blood urea increased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with NAFAMOSTAT MESILATE, SOLDEM, PREDNISOLONE, FUROSEMIDE, RANITIDINE HYDROCHLORIDE, OMEPRAZOLE, HICALIQ, SOHVITA. Patient died.

Danaparoid Side Effects Report #5056237-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 27, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, gamma-glutamyltransferase increased, leukopenia, malnutrition. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.


Danaparoid Side Effects Report #5056239-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, disease progression, fibrin degradation products increased, gamma-glutamyltransferase increased, leukopenia. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.

Danaparoid Side Effects Report #5062425-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, disease progression, fibrin degradation products increased, gamma-glutamyltransferase increased, haemorrhagic diathesis. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.

Danaparoid Side Effects Report #4708472-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 28, 2005. Male patient, 72 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, pancreatitis, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, LEVOTHYROXINE, FERROUS FUMARATE, URSODEOXYCHOLIC ACID, GLYCYRRHIZIC ACID, GLUTATHIONE, VANCOMYCIN, FUROSEMIDE. Patient recovered.

Danaparoid Side Effects Report #4985074-1
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2005. Female patient, 66 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac tamponade, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with GLYCEOL, CEFPIROME SULPHATE, EDARAVONE. Patient died.

Danaparoid Side Effects Report #5062431-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, fibrin d dimer increased. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, DAUNOMYCIN, CYTARABINE, ANTITHROMBIN III, MINOPHAGEN C, CEFTAZIDIME. Patient recovered.


Danaparoid Side Effects Report #5116968-4
Danaparoid side effect was reported by a Health Professional from JAPAN on Sept 13, 2006. Female patient, 49 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, MINOCYCLINE HYDROCHLORIDE, CILASTATIN W, OMEPRAZOLE, NAFAMOSTAT MESILATE, SIVELESTAT, DOPAMINE. Patient died.

Danaparoid Side Effects Report #5153402-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Female patient, 49 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, condition aggravated, gamma-glutamyltransferase increased, hepatic function abnormal, liver disorder. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, ANTITHROMBIN III, MINOCYCLINE, CILASTATIN W, OMEPRAZOLE, NAFAMOSTAT MESILATE, SIVELESTAT, DOPAMINE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5123364-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 40 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood lactate dehydrogenase increased, condition aggravated, disease progression, disseminated intravascular coagulation, hepatic function abnormal, platelet count increased, protein total decreased, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, IMMUNE GLOBULIN INTRAVENOUS, GABEXATE MESILATE, ANTITHROMBIN III, ULINASTATIN, HAPTOGLOBIN. Patient died.

Danaparoid Side Effects Report #6029416-7
Danaparoid side effect was reported by a Physician from CANADA on Dec 22, 2008. Female patient, 64 years of age, was diagnosed with prophylaxis and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, adrenal disorder, adrenal haemorrhage, adrenal insufficiency, amnesia, blood lactate dehydrogenase increased, calcinosis, cerebral ischaemia, deep vein thrombosis . Danaparoid dosage: unknown. During the same period patient was treated with FONDAPARINUX, ARGATROBAN, DALTEPARIN. Patient recovered.